Stock OSCR OSCAR HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Oscar Health, Inc.

Equities

OSCR

US6877931096

Market Closed - Nyse
Other stock markets
 16:00:02 2024-04-29 EDT 		5-day change 1st Jan Change
17.4 USD -0.91% Intraday chart for Oscar Health, Inc. +7.54% +90.16%
03-22 Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target MT
03-18 Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company is in a robust financial situation considering its net cash and margin position.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.25 for the 2024 fiscal year.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
OSCAR HEALTH, INC. Stock Oscar Health, Inc.
+90.16% 4.16B -
BUPA ARABIA FOR COOPERATIVE INSURANCE COMPANY Stock Bupa Arabia for Cooperative Insurance Company
+11.81% 9.58B
B-
MEDIBANK PRIVATE LIMITED Stock Medibank Private Limited
-0.14% 6.39B
C+
NIB HOLDINGS LIMITED Stock nib holdings limited
+0.07% 2.31B
B+
TRUPANION, INC. Stock Trupanion, Inc.
-21.34% 1.01B
C
RELIGARE ENTERPRISES LIMITED Stock Religare Enterprises Limited
+3.85% 862M -
D+
THE MEDITERRANEAN AND GULF COOPERATIVE INSURANCE AND REINSURANCE COMPANY Stock The Mediterranean and Gulf Cooperative Insurance and Reinsurance Company
+83.33% 718M -
C
AMANA COOPERATIVE INSURANCE COMPANY Stock Amana Cooperative Insurance Company
+3.52% 155M - -
PT LIPPO GENERAL INSURANCE TBK Stock PT Lippo General Insurance Tbk
-6.42% 68.79M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. OSCR Stock
  4. Ratings Oscar Health, Inc.